Results 41 to 50 of about 136,561 (344)

The role of CD24 as a potential biomarker for malignant pleural mesothelioma

Egyptian Journal of Chest Disease and Tuberculosis, 2023
Objectives Pleural mesothelioma is a rapidly progressing pleural neoplasm caused by asbestos exposure of a long latency around 30-40 years. Patients with mesothelioma are usually diagnosed at a late stage with poor outcomes in terms of morbidity and ...
Mohamed Shaaban Mousa, Ahmed Mamdooh Ghoname, Dalia Abd El-Kareem Ateya, Hamed A H Abdallah, Salwa Hassan Ahmed   +4 more
doaj   +1 more source

Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

Ca, 2019
Mesothelioma affects mostly older individuals who have been occupationally exposed to asbestos. The global mesothelioma incidence and mortality rates are unknown, because data are not available from developing countries that continue to use large amounts
M. Carbone, P. Adusumilli, H. Alexander, P. Baas, F. Bardelli, Angela Bononi, R. Bueno, E. Felley-Bosco, F. Galateau-Salle, D. Jablons, A. Mansfield, Michael Minaai, M. Perrot, P. Pesavento, V. Rusch, D. T. Severson, E. Taioli, A. Tsao, G. Woodard, Haining Yang, M. Zauderer, H. Pass   +21 more
semanticscholar   +1 more source

Estimating past inhalation exposure to asbestos: a tool for risk attribution and disease screening [PDF]

, 2017
Introduction: Late presentation is common in mesothelioma. Reliable assessment of past exposure to asbestos is a necessary first step for risk attribution and for the development of a future screening programme. Such a programme could maximise access
Blyth, Kevin G., Cherrie, John W., McElvenny, Damien   +2 more
core   +1 more source

Recommendations for improving follow-up care for patients with mesothelioma: a qualitative study comprising documentary analysis, interviews and consultation meetings

BMJ Open, 2021
Objectives The study aim was to explore experiences of patients with pleural mesothelioma of follow-up care in three National Health Service (NHS) Trusts to develop recommendations for practice.Design The study design was qualitative and comprised three ...
Najib Rahman, Catherine Henshall, Zoe Davey, Helen Walthall, Hannah Ball, Mitra Shahidi, John Park   +6 more
doaj   +1 more source

Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting [PDF]

, 2019
The management of patients with mesothelioma and thymic malignancy requires continuous multidisciplinary expertise at any step of the disease. A dramatic improvement in our knowledge has occurred in the last few years, through the development of ...
Girard, N, Grassino, M, Imbimbo, M, Maury, J, Vitale, F   +4 more
core   +1 more source

Matrix Metalloproteinases as Biomarkers and Treatment Targets in Mesothelioma: A Systematic Review

Biomolecules, 2021
Metalloproteinases (MMPs) have an important role in tissue remodeling and have been shown to have an effect on tumor progression, invasion, metastasis formation, and apoptosis in several tumors, including mesothelioma.
Danijela Štrbac, Vita Dolžan
doaj   +1 more source

Can malignant and inflammatory pleural effusions in dogs be distinguished using computed tomography [PDF]

, 2017
Computed tomography (CT) is the primary imaging modality used to investigate human patients with suspected malignant or inflammatory pleural effusion, but there is a lack of information about the clinical use of this test in dogs.
Aquino, Bedford, Benamore, Caivano, Ceribasi, Charney, D'Angelo, Dempsey, Dubielzig, Echandi, Fossum, Gumber, Hirsch, Hung, Kawashima, Lara-Garcia, Metintas, Morrison, Mott, Müller, Nakamura, Prather, Przeździecki, Rebar, Reetz, Sahin, Smith, Swinbourne, Thrall, Traill, Tyler, Vansteenkiste, Vogtli, Waite, Wang, Yamamoto   +35 more
core   +1 more source

Survival prediction in mesothelioma using a scalable lasso regression model: instructions for use and initial performance using clinical predictors [PDF]

, 2018
Introduction: Accurate prognostication is difficult in malignant pleural mesothelioma (MPM). We developed a set of robust computational models to quantify the prognostic value of routinely available clinical data, which form the basis of published MPM ...
Blyth, Kevin G., Bylesjo, Max, Halligan, Daniel L., Kidd, Andrew C., McGettrick, Michael, Tsim, Selina   +5 more
core   +1 more source

The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy. [PDF]

, 2011
BackgroundTumor microenvironments present significant barriers to penetration by antibodies and immunoconjugates. Tumor microenvironments, however, are difficult to study in vitro.
Broaddus, V Courtney, Feng, Mingqian, Fitzgerald, David, Hassan, Raffit, Ho, Mitchell, Nagashima, Kunio, Phung, Yen, Xiang, Xinran, Zhang, Jingli   +8 more
core   +3 more sources

Mesothelioma in Scotland [PDF]

BMJ, 1970
In a retrospective study of the incidence of mesothelioma in Scotland for 1950-67 80 cases were traced from pathological reports and biopsy material of malignant tumours invading the pleura and peritoneum. These cases were matched with two sets of controls.
A. A. M. Gibson, J. McEwen, Angela Finlayson, A. Mair   +3 more
openaire   +3 more sources